Bill Miller
Miller Value Partners
Bill Miller Gilead Sciences Inc stake
total: 460
Miller Value Partners GILD trades
- Total transactions:
- 13
- New positions:
- 1
- Sold out:
- 1
- Added:
- 2
- Reduced:
- 9
- Held since:
- 2014 Q2
- Held for:
- 14 quarters
- Latest activity:
- 2017 Q4
According to 2026 Q1 report, Bill Miller doesn't hold any Gilead Sciences Inc (GILD) shares. To date, the estimated cost basis is nearly $84.53 for "buy" trades and estimated average "sell" price is $83.72. Miller Value Partners first purchased GILD in 2014 Q2, initially acquiring 670,075 shares. Since the initial investment in Gilead Sciences Inc (GILD), Miller Value Partners has made 12 more transactions.
When did Bill Miller sell Gilead Sciences Inc (GILD)?
Bill Miller sold off the entire Gilead Sciences Inc (GILD) position in 2017 Q4.
When did Bill Miller buy Gilead Sciences Inc (GILD)?
Bill Miller first invested in Gilead Sciences Inc (GILD) in 2014 Q2 at the reported quarter-end price of $82.91 per share.
What's the cost basis of Miller Value Partners's GILD stake?
The estimated cost basis for Gilead Sciences Inc (GILD) stake is around $84.53 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $84.53
- Weighted AVG sell price:
- $83.72
Bill Miller's historical trades in Gilead Sciences Inc
13 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2017 Q4
|
0.00%
|
$81.02
|
-100% (-322,955)
|
|||
|
2017 Q3
|
1.20%
|
$81.02
|
-12.63% (-46,705)
|
|||
|
2017 Q2
|
1.19%
|
$70.78
|
-2.01% (-7,590)
|
|||
|
2017 Q1
|
1.33%
|
$67.92
|
-19.05% (-88,800)
|
|||
|
2016 Q4
|
1.78%
|
$71.61
|
-0.96% (-4,500)
|
|||
|
2016 Q3
|
2.12%
|
$79.12
|
-2.08% (-10,000)
|
|||
|
2016 Q2
|
2.59%
|
$83.42
|
-8.24% (-43,125)
|
|||
|
2016 Q1
|
2.39%
|
$91.86
|
-9.33% (-53,900)
|
|||
|
2015 Q4
|
2.24%
|
$101.19
|
+7.14% (+38,475)
|
|||
|
2015 Q1
|
2.00%
|
$98.13
|
-21.72% (-149,575)
|
|||
|
2014 Q4
|
2.54%
|
$94.26
|
-0.23% (-1,600)
|
|||
|
2014 Q3
|
3.12%
|
$106.45
|
+3.01% (+20,200)
|
|||
|
2014 Q2
|
2.23%
|
$82.91
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.